GDF-15与uEGF独立关联儿童CKD进展
在4C队列671例6-17岁CKD患儿中,血清GDF-15升高与CKD进展风险增加独立相关(HR 1.40,95%CI 1.10-1.77),且与uEGF联合可进一步改善模型拟合,并在ESCAPE试验329例中外部验证。
要点
- 血清GDF-15升高独立关联儿童CKD进展风险增加。
- GDF-15与uEGF联合较单用任一标志物进一步改善模型拟合。
- 两标志物或可纳入未来儿童CKD预后生物标志物组合。
核心结论
- 血清GDF-15和尿EGF水平可能提供儿童CKD进展风险的互补信息。
研究设计与样本
- 在4C研究671例6-17岁、基线eGFR 10-60 ml/min per 1.73 m2的CKD患儿中分析GDF-15与CKD进展关联,中位随访8年。
- 结果在ESCAPE试验329例参与者中外部验证。
主要发现
- 较高GDF-15水平与CKD进展风险增加相关(HR 1.40,95%CI 1.10-1.77),独立于年龄、性别、基线eGFR、蛋白尿和收缩压。
- 将GDF-15或uEGF单独加入含上述变量的模型均改善模型拟合,两者联合进一步改善。
- ESCAPE队列外部验证确认了上述结果。
关键数值与推荐
- 复合终点为开始肾脏替代治疗、eGFR下降50%或eGFR<10 ml/min per 1.73 m2。
临床怎么用
- 血清GDF-15与尿EGF或可用于儿童CKD风险分层,支持个体化管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Currently, there is limited ability to predict the progression of chronic kidney disease (CKD) in children. Previously we reported that low levels of urinary epidermal growth factor (uEGF) predict CKD progression in children. In the present study, we investigated a novel serum biomarker, growth differentiation factor 15 (GDF-15), in 2 European pediatric CKD cohorts. We additionally explored the combined effect of GDF-15 and/or uEGF on CKD progression in children. METHODS: The association between serum GDF-15 levels and CKD progression was analyzed in 671 patients of the Cardiovascular Comorbidity in Children with CKD (4C) study, aged 6 to 17 years with an estimated glomerular filtration rate (eGFR) of 10 to 60 ml/min per 1.73 m2 at baseline, and median follow-up of 8 years. The composite end point was start of kidney replacement therapy, 50% eGFR loss, or eGFR < 10 ml/min per 1.73 m2. Results were validated in 329 participants from the ESCAPE trial. RESULTS: Higher GDF-15 levels were associated with an increased risk of CKD progression (hazard ratio: 1.40; 95% confidence interval [CI]: 1.10-1.77), independent of age, sex, baseline eGFR, proteinuria, and systolic blood pressure. Whereas adding either GDF-15 or uEGF individually to a model containing these variables improved model fit, combining both markers improved the model further. External validation in the ESCAPE cohort confirmed these results. CONCLUSION: Serum GDF-15 and urine EGF levels may provide complementary information on the risk of CKD progression in children and might be included in future prognostic biomarker panels aimed at personalized, risk-stratified management of pediatric CKD.
引用
- Bartels J, Tabatabaeifar M, Kirchner M, et al. GDF-15 and uEGF Independently Associate With CKD Progression in Children. Kidney Int Rep. 2025. PMID: 41141543. doi:10.1016/j.ekir.2025.07.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。